{"name":"Edelman, Martin, M.D.","slug":"edelman-martin-m-d","ticker":"","exchange":"","domain":"","description":"Edelman, Martin, M.D. is a specialty pharmaceutical company focused on developing and commercializing innovative treatments in oncology. The company has a single drug in its pipeline, UFT (Tegafur/Uracil), which is currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQNnBEajVqU1FuMFlhb3llWkpZTEpTTmJFVnhoOUpUOVM5TGZTR0FiYjdqNmxfcjRyeEVpMnVIS3ZzNVYyNXBsOUUyc2JxRHhPN1hJTF80eWJfdDlPMGhnamJEdXdYWGJKdmpVdy1xSll0UE1zdmNyYzBPYTVVZzJCczZpMW1sWEpMUW9ld05QczRpUnhmUHdpMkJMQ0JhblNBa1UwaGdPUFZqNk5hN1dXbTFyRWVJYWgtaVVjQm80YlBnSlN5bHZRLVk5clZrVG9xdDVkWkhkMA?oc=5","date":"2023-08-04","type":"pipeline","source":"Healio","summary":"Lung cancer specialist named medical oncology department chair at Temple University - Healio","headline":"Lung cancer specialist named medical oncology department chair at Temple University","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNenFVdGFSOU4tT3FUalh5ODlnUEl0Tzh1ZlJEZTVzZFVzUmNQTGNNYkhESFJzMlpiUV93Z3FTTmZSTFFXSDdTRGJoRWlQWS1IemR5Znd6bHdyaE11dDNndDdrZHFCRVNBZlZvYTlEZllvcV9GS0E3UHh5dHJyUWJfcmdYUnhzSGZuMWRaOEczbFFGNjFFbkt4TjQzOGFDTE9zRS0tek95YzJ1bGxxZ2FUMmhhcnNtTGNPR3RWTHdpUWJiZW1JdmttT3QwODhWdw?oc=5","date":"2019-10-23","type":"pipeline","source":"Healio","summary":"Deadliest cancers receive less research funding from patient advocacy groups - Healio","headline":"Deadliest cancers receive less research funding from patient advocacy groups","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}